| 摘要 |
The invention relates to a medicamentation for the treatment of prevention of migraine comprising an inhibitor of CGRP (1) and at least one cyclooxygenase-2 inhibitor or a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof (2), and a pharmaceutically acceptable carrier or excipient, and optionally one or more other therapeutic ingredients.
|
